| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |